Synthesis, Characterization and Cytotoxic Evaluation of New Pyrrolo[1,2- b]pyridazines Obtained via Mesoionic Oxazolo-Pyridazinones

Int J Mol Sci. 2023 Jul 19;24(14):11642. doi: 10.3390/ijms241411642.

Abstract

New pyrrolo[1,2-b]pyridazines were synthesized by 3 + 2 cycloaddition reaction between mesoionic oxazolo-pyridazinones and methyl/ethyl propiolate. The mesoionic compounds were generated in situ by action of acetic anhydride on 3(2H)pyridazinone acids obtained from corresponding esters by alkaline hydrolysis followed by acidification. The structures of the compounds were confirmed by elemental analyses and IR, 1H-NMR, 13C-NMR, and X-ray diffraction data. The regioselectivity of cycloaddition was evidenced by NMR spectroscopy and confirmed by X-ray analysis. The compounds were evaluated for their cytotoxicity on plant cells (Triticum aestivum L.) and crustacean animal cells (Artemia franciscana Kellogg and Daphnia magna Straus). The results indicated that the tested compounds exhibited low toxicity on the plant cell (IC50 values higher than 200 µM), while on Artemia nauplii no lethality was observed. Daphnia magna assay showed that pyrrolo[1,2-b]pyridazines 5a and 5c could exhibit toxic effects, whereas, for the other compounds, toxicity was low to moderate. Also, the cytotoxic effects of the compounds were tested on three human adenocarcinoma-derived adherent cell lines (colon LoVo, ovary SK-OV-3, breast MCF-7). The in vitro compound-mediated cytotoxicity assays, performed by the MTS technique, demonstrated dose- and time-dependent cytotoxic activity for several compounds, the highest anti-tumor activity being observed for 5a, 2c, and 5f, especially against colon cancer cells.

Keywords: 3 + 2 cycloaddition; X-ray diffraction; antitumor activity; cytotoxicity; dipolarophile alkynes; mesoionic oxazolo-pyridazinones; pyrrolo[1,2-b]pyridazines.

MeSH terms

  • Animals
  • Antineoplastic Agents* / chemistry
  • Cell Proliferation
  • Drug Screening Assays, Antitumor
  • Humans
  • Molecular Structure
  • Pyridazines* / chemistry
  • Structure-Activity Relationship

Substances

  • Pyridazines
  • Antineoplastic Agents

Grants and funding

This research was funded by the “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania, Publish not Perish Grants.